Anti-mitochondrial antibody titers decrease over time in primary biliary cholangitis patients with ursodeoxycholic acid therapeutic response: a cohort study followed up …
ML Chang, WT Chen, TM Chan, CY Lin… - Frontiers in …, 2022 - frontiersin.org
Background How anti-mitochondrial antibody (AMA) and liver biochemistry levels change in
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …
Evidence for the association between IgG‐antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis
L Tang, R Zhong, X He, W Wang, J Liu… - Journal of …, 2017 - Wiley Online Library
Abstract Background and Aim Antimitochondrial antibody (AMA) is considered the
serological hallmark of primary biliary cholangitis (PBC), while data regarding the profile of …
serological hallmark of primary biliary cholangitis (PBC), while data regarding the profile of …
Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver …
WR Kim, JJ Poterucha, RA Jorgensen, KP Batts… - Hepatology, 1997 - journals.lww.com
Abstract Approximately 5% to 10% of patients with features otherwise consistent with
primary biliary cirrhosis (PBC) lack antimitochondrial antibodies (AMA). Most of these …
primary biliary cirrhosis (PBC) lack antimitochondrial antibodies (AMA). Most of these …
Anti-mitochondrial antibody-negative primary biliary cholangitis is part of the same spectrum of classical primary biliary cholangitis
GGL Cançado, MH Braga, MLG Ferraz… - Digestive diseases and …, 2021 - Springer
Background Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease in which
anti-mitochondrial antibodies (AMA) are the diagnostic hallmark. Whether AMA-negative …
anti-mitochondrial antibodies (AMA) are the diagnostic hallmark. Whether AMA-negative …
Low rate of new‐onset primary biliary cholangitis in a cohort of anti‐mitochondrial antibody‐positive subjects over six years of follow‐up
S Zandanell, M Strasser, A Feldman… - Journal of Internal …, 2020 - Wiley Online Library
Abstract Background and Aims Anti‐mitochondrial antibodies (AMA) are closely linked to
primary biliary cholangitis (PBC). The prevalence of AMA in the general population is low …
primary biliary cholangitis (PBC). The prevalence of AMA in the general population is low …
Rates of decompensation, hepatocellular carcinoma and mortality in AMA‐negative primary biliary cholangitis cirrhosis
Background The natural history of patients with anti‐mitochondrial antibody (AMA)‐negative
Primary Biliary Cholangitis (PBC) cirrhosis has not been well defined, with prior studies …
Primary Biliary Cholangitis (PBC) cirrhosis has not been well defined, with prior studies …
Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China
L Feng, K Dong, X Zhang, B Ma, L Chen, Q Yang… - Plos one, 2020 - journals.plos.org
Background and objective The relationship between antimitochondrial antibody (AMA)
levels and the severity or prognosis of primary biliary cholangitis (PBC) is unclear. This study …
levels and the severity or prognosis of primary biliary cholangitis (PBC) is unclear. This study …
The challenges of primary biliary cholangitis: What is new and what needs to be done
BT Beretta-Piccoli, G Mieli-Vergani, D Vergani… - Journal of …, 2019 - Elsevier
Abstract Primary Biliary Cholangitis (PBC) is an uncommon, chronic, cholangiopathy of
autoimmune origin and unknown etiology characterized by positive anti-mitochondrial …
autoimmune origin and unknown etiology characterized by positive anti-mitochondrial …
Evolutionary relationship between antimitochondrial antibody positivity and primary biliary cholangitis in Taiwan: a 16-year hospital cohort study
ML Chang, JS Cheng, PH Le… - Therapeutic …, 2024 - journals.sagepub.com
Background: How antimitochondrial antibody (AMA)-positive patients evolve to have primary
biliary cholangitis (PBC) in viral hepatitis–endemic areas is unknown. Objectives: We aimed …
biliary cholangitis (PBC) in viral hepatitis–endemic areas is unknown. Objectives: We aimed …
[PDF][PDF] The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti‐mitochondrial antibodies but without baseline PBC
W Duan, S Chen, S Li, T Lv, B Li… - Hepatology …, 2022 - Wiley Online Library
Anti‐mitochondrial autoantibodies (AMAs) are highly specific for the diagnosis of primary
biliary cholangitis (PBC) but are also occasionally found in other diseases. In the present …
biliary cholangitis (PBC) but are also occasionally found in other diseases. In the present …